BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4106 related articles for article (PubMed ID: 12563091)

  • 1. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstructing the course of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Cantó-Nogués C; Muñoz-Fernández A
    Med Sci Monit; 2002 Oct; 8(10):RA249-52. PubMed ID: 12395135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of viral load and CD8 T-lymphocytes with development of neurological manifestations in vertically HIV-1-infected infants. A prospective longitudinal study.
    Gurbindo D; Resino S; Sánchez-Ramón S; León JA; Muñoz-Fernández MA
    Neuropediatrics; 1999 Aug; 30(4):197-204. PubMed ID: 10569211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
    Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
    Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years.
    Arnó A; Ruiz L; Juan M; Zayat MK; Puig T; Balagué M; Romeu J; Pujol R; O'Brien WA; Clotet B
    AIDS; 1998 May; 12(7):697-704. PubMed ID: 9619800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M; Cordero M; Almeida J; Orfao A
    Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.
    Resino S; Seoane E; Gutiérrez MD; León JA; Muñoz-Fernández MA
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):269-76. PubMed ID: 16810122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children].
    Resino S; Sánchez-Ramón S; Correa R; Navarro ML; Bellón JM; Muñoz-Fernández MA
    Med Clin (Barc); 2003 Mar; 120(11):417-20. PubMed ID: 12681220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy.
    Paul ME; Mao C; Charurat M; Serchuck L; Foca M; Hayani K; Handelsman EL; Diaz C; McIntosh K; Shearer WT;
    J Allergy Clin Immunol; 2005 Apr; 115(4):848-55. PubMed ID: 15806009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
    Iannetta M; Savinelli S; Rossi R; Mascia C; Marocco R; Vita S; Zuccalà P; Zingaropoli MA; Mengoni F; Massetti AP; Falciano M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V; Lichtner M
    Immunobiology; 2019 Mar; 224(2):231-241. PubMed ID: 30522891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T-lymphocyte count/CD8+ T-lymphocyte count ratio: surrogate for HIV infection in infants?
    Navaneethapandian PG; Karunaianantham R; Subramanyan S; Chinnayan P; Chandrasekaran P; Swaminathan S
    J Trop Pediatr; 2012 Oct; 58(5):394-7. PubMed ID: 22228820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
    Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
    Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A cross-sectional study on the effect of virological response after HAART on subsets of T lymphocytes and expression of CD127 in pediatric AIDS patients with different viral loads].
    Wu LJ; Wu LX; Bai S
    Zhonghua Er Ke Za Zhi; 2013 Sep; 51(9):659-64. PubMed ID: 24330984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic markers of progression to AIDS in infants vertically infected by human immunodeficiency virus type-1].
    Resino S; Bellón JM; Gurbindo D; Ramos JT; Ruiz Contreras J; Muñoz-Fernández MA
    Med Clin (Barc); 2000 Nov; 115(15):564-7. PubMed ID: 11141389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 206.